Atlas Trials

Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)

Clinical trial NCT04656652 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04656652
Sponsor
Daiichi Sankyo
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2020-12-21
Primary completion
2024-05-10
Enrollment
605

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.